SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

**Aventus Network** ($AVT) is trending as the community discusses its potential breakout, citing integration with **Polkadot**, enterprise partnerships, and a low market cap. Bullish traders are highlighting oversold conditions as a catalyst for a potential rally, while closely monitoring volume and potential new exchange listings. The network's strategic advisory appointment in the **UAE** is also generating buzz.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

CVNA is trending as the community discusses its potential S&P 500 inclusion and the implications of its high valuation amidst concerns of market corruption and subprime lending practices. Community sentiment is divided, with some anticipating further gains driven by market dynamics, while others foresee an impending correction. Discussions also include potential shorting opportunities and the long-term viability of Carvana's business model.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic ($LUNC) is trending as the community discusses potential ecosystem rebuilding, token burns, and the upcoming Do Kwon court hearings. Some are speculating on possible price movements based on the trial's outcome, while others are debating the merits of holding LUNC amidst exchange delistings and past losses. Bullish investors highlight potential upgrades to the Binance network and long-term comeback potential, drawing comparisons to other tokens that recovered from regulatory hurdles.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TGL is trending due to a massive surge, driven by its small float and potential short squeeze, reminding some traders of SMX's previous run. Community members are actively discussing its volatile price action, potential for further gains, and whether shorts will be squeezed even more. The stock's reverse split and news catalysts may be contributing to the increased attention.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is trending as community members discuss its durable position with familiar EVM tooling, tight exchange integration, and real builder subsidies.  Discussion highlights the Keeta project and whether a Keeta position is worth studying as an asymmetric, infra-focused complement rather than a competitor to existing BNB holdings.  Many are watching for a potential upgrade to the exchange platform and possible effects on the LUNA ecosystem.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending due to an 8K filing indicating plans to seek FDA approval for AXPAXLI based on SOL-1 results, a move seen as bold and potentially accelerating the drug's path to market. Community discussion revolves around the implications of this decision, with some speculating positive data from the trial and potential for a Monday morning press release to further boost investor confidence. The focus remains on AXPAXLI's potential in the wet AMD market and the company's strategic positioning within the broader ophthalmology sector.

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is trending as the community discusses its potential, particularly around staking rewards and a recently launched DEX.  Some view it as a promising, undervalued project with a functional Ethereum bridge, while others express concerns about liquidity and past performance. Debate centers on its long-term potential versus its current status as a 'shitcoin.'

Boba Network is a blockchain Layer-2 scaling solution and Hybrid Compute platform offering lightning fast transactions and fees up to 100x less than Layer-1. Our Hybrid Compute technology brings the power of Web2 on-chain for the first time, allowing smart contracts to call any external Web2 API to execute complex algorithms such as machine learning classifiers, pull in real-world or enterprise data in a single atomic transaction, or sync with the latest state of a gaming engine. Leveraging off-chain compute and real-world data, developers and creators can offer an enriched experience unlike anything else on the market today.

Boba Network

Boba Network ($BOBA) is trending amid community excitement around potential partnerships and recent bullish technical indicators. Discussions highlight its potential for significant gains, drawing comparisons to past performance and other altcoins. Investors are closely watching for a breakout, anticipating a run towards previous highs.

Irys is a Layer 1 datachain that unifies onchain data storage and smart contract execution into a single network. Traditional smart contract chains handle financial transactions but lack native primitives for working with data at scale. Traditional datachains handle storage but lack integration with smart contracts. Irys serves both. Irys bridges this gap by unifying storage and execution, making data programmable through IrysVM, its native EVM execution layer. The network offers flexible storage options: users can choose between term storage (temporary, duration-based) or permanent storage (one-time payment for perpetual retention). Both operate at at-cost pricing, made possible by Irys's multi-revenue model that combines storage fees, execution fees, and programmable data transactions. This design allows Irys to remain competitive on price while maintaining economic sustainability. Irys achieves instant data retrieval and infinite horizontal scaling. As demand grows, the network expands capacity by adding validators who prove continuous maintenance of their assigned data partitions. The network's native token, $IRYS, is used for all storage and execution fees, as well as validator staking.

Irys

Irys (IRYS) is trending amid discussions about potential partnerships with other cryptocurrencies like ETH and XRP, with some community members highlighting its low supply and high demand. There's also speculation around its connection to AI and potential support from major players like NVDA and INTC, with some comparing it to other trending cryptos. Community members are actively discussing entry and exit points, with some focusing on long-term potential and others pointing to shorter-term profit-taking opportunities.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis ($TCNNF) is trending amid discussions surrounding potential rescheduling and its impact on the cannabis sector, with some seeing the current price as a buying opportunity. Community members are actively sharing articles about the company and broader cannabis industry developments, as well as debating potential catalysts, including the upcoming midterms and Florida's recreational initiative. Talk is circulating on social media activity from figures potentially connected to favorable cannabis reform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Bloomberg reported that the Centers for Medicare &amp; Medicaid Services (CMS), which runs the Medicare program, is planning an initiative that would make some U.S. Medicare patients eligible for CBD coverage.&nbsp;</li><li>MSOS and YOLO, two key cannabis sector-focused funds, gained 3.4% and 2.7%, respectively.</li><li>The Trump administration seems to be backing cannabis as an industry, following its previous comments regarding CBD and reclassifying marijuana.</li></ul>Cannabis&nbsp;stocks advanced on Wednesday following a report speculating that certain U.S Medicare patients could soon be eligible to receive coverage for CBD under a new initiative.CBD, or cannabidiol, is a compound found in cannabis and used to treat sleep disorders, anxiety, pain, and inflammation. Some research suggests it may also treat cancer symptoms. The drug is sold as gummies, pet treats, and skincare supplements.<h2 class="st-heading-2">Cannabis Stocks Rally</h2>Tilray Brands’ shares rose 4.8%, while the over-the-counter stocks of Curaleaf Holdings, Trulieve Cannabis, and Green Thumb Industries gained between 2% to 5.6%. Shares of Innovative Industrial Properties, a real estate investment trust (REIT) that buys and leases specialized cannabis cultivation facilities, rose 1.1%.On Stocktwits, the retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/TLRY">TLRY</a> shifted to ‘extremely bullish’ from ‘bullish,’ while that for&nbsp;<a href="https://stocktwits.com/symbol/CURLF">CURLF</a> shifted to ‘bullish’ from ‘neutral.’ The sentiment was ‘bullish’ for&nbsp;<a href="https://stocktwits.com/symbol/GTBIF">GTBIF</a>, and ‘bearish’ for&nbsp;<a href="https://stocktwits.com/symbol/GTBIF">TCNNF</a> and&nbsp;<a href="https://stocktwits.com/symbol/IIPR">IIPR</a> as of the last reading.&nbsp;The&nbsp;<a href="https://stocktwits.com/symbol/MSOS">AdvisorShares Pure US Cannabis ETF (MSOS)</a>, which tracks U.S. cannabis companies exclusively, and the&nbsp;<a href="https://stocktwits.com/symbol/YOLO">AdvisorShares Pure Cannabis ETF (YOLO)</a>, which also tracks overseas companies and cannabis-adjacent businesses, rose 3.4% and 2.7%, respectively.<h2 class="st-heading-2">CMS Initaitive</h2>The rally came after Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-11-26/medicare-to-test-making-cbd-treatment-available-for-seniors">reported</a> that the Centers for Medicare &amp; Medicaid Services (CMS) is planning an initiative that would make some U.S. Medicare patients eligible for CBD coverage.&nbsp;Details of the proposed program aren’t available, but an early version of the plan focused on seniors in oncology and palliative care settings, according to a summary viewed by the news agency.Unnamed sources told Bloomberg that Howard Kessler, a payments financier who has advocated for expanded CBD access, met with Health and Human Services Secretary Robert F. Kennedy Jr. about the issue last month<h2 class="st-heading-2">A Trump Boost?</h2>The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare. Hemp-derived cannabidiol (CBD) could "revolutionize senior healthcare" by slowing disease progression and serving as an alternative to prescription drugs, Trump had&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tilray-canopy-growth-cannabis-stocks-lose-high-premarket-after-surge-triggered-by-trumps-post/chDDTJ9R3BB">said</a> in a video post in September.The previous month, Trump said his administration was weighing a move to reclassify marijuana as a less dangerous drug under federal law.That said, doubts over cannabis efficacy in healthcare remain. A&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2836267">recent study</a> funded by the Food and Drug Administration suggested that prolonged use of CBD may cause liver toxicity, while other research suggests it can interfere with other medications, harm male reproductive health, and pose potential risks to children and pregnant women.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/holiday-shopping-could-soar-to-a-record-1-trillion-this-year-with-online-spending-blasting-to-new-highs/cL5eLqVREW6">Holiday Shopping Could Soar To A Record $1 Trillion This Year, With Online Spending Blasting To New Highs</a>

Cannabis plants grow in the greenhouse at Vireo Health's medical marijuana cultivation facility, August 19, 2016 in Johnstown, New York. (Photo by Drew Angerer/Getty Images)

Tilray, IIPR, Trulieve, Other Cannabis Stocks Rally On Report Of Government Considering Adding CBD Treatment For Medicare Patients  

The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare. 

Equity

The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO

Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects 

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism. 

Top-Performing ETFs of Last Week

ETFs tied to cannabis, Ethereum and Chinese tech stocks topped last week's winners list. Top performers were KSTR, YOLO, ARKZ, CHIQ and CNXT.

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.


Nasdaq-listed shares of Canopy Growth Corp. (CGC) fell 12% in pre-market trading on Friday after the cannabis company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.canopygrowth.com/investors/news-releases/canopy-growth-reports-fourth-quarter-and-fiscal-year-2025-financial-results/">reported</a> wider-than-expected fourth-quarter (Q4) loss.The company’s fourth quarter revenue fell 11% year-on-year (YoY) to C$65.03 million ($47.16 million), below an analyst estimate of C$70.87 million, according to Finchat data.The company attributed the drop to a decline in net revenue from its international markets cannabis, and Storz &amp; Bickel segments.In Canada, cannabis net revenue was C$40 million in the quarter, marking an increase of 4% YoY. However, across international markets, the revenue declined 35% YoY to C$8 million, owing to a decline in medical cannabis sales in Poland and Australia, the company said.Storz and Bickel, meanwhile, delivered net revenue of C$17 million in the quarter, a decrease of 23% YoY, owing to softer consumer demand for its devices. Storz and Bickel designs vaporizers for combustion-free vaporization and inhalation of dry herbs.The company’s gross margin fell by 500 basis points to 16% in the quarter, and it reported an adjusted loss before interest, taxes, depreciation, and amortisation (EBITDA) of C$9 million. Analysts had only expected a loss of C$3.13 million.The company’s total debt, however, decreased to C$304 million as of March 31, compared to C$597 million on the corresponding date of 2024.The company said on Friday that it plans to continue to focus on accelerating growth in global medical cannabis, improving commercial execution, and profitability in Canada’s adult-use cannabis market. The company also said that cost actions are underway and it expects annualized savings of at least C$20 million over the next 12 to 18 months.CFO Judy Hong also said that the company is committed to achieving positive adjusted EBITDA in the “near-term,” without specifying a timeline.On Stocktwits, retail sentiment around Canopy Growth stayed within the ‘bearish’ territory over the past 24 hours while message volume rose from ‘normal’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:627/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_30_at_8_59_37_AM_png_cf8cb9e0cf.webp" alt="CGC's Sentiment Meter and Message Volume as of 8:15 a.m. ET on May 30, 2025 | Source: Stocktwits" width="627" height="64"><figcaption>CGC's Sentiment Meter and Message Volume as of 8:15 a.m. ET on May 30, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user termed the Q4 earnings reports “a pretty big let down.” &nbsp;<stembedurl>https://stocktwits.com/JustAGlitchBTMFD/message/616291899</stembedurl><a href="https://stocktwits.com/symbol/CGC">CGC stock </a>is down by about 41% this year and by about 80% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/zymeworks-drug-gets-conditional-approval-for-biliary-tract-cancer-in-china/ch0Mun4RbMx">Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.(Exchange Rate: I Canadian Dollar= 0.73 US Dollar)

A cart full of bagged marijuana is rolled through the corridors at the Canopy Growth Corporation headquarters in Smiths Falls, Ontario, on May 15, 2019. (Photo by Lane Turner/The Boston Globe via Getty Images)

Canopy Growth Stock Drops Pre-Market After Disappointing Q4 Earnings: Retail Terms It ‘A Pretty Big Let Down’

CFO Judy Hong said the company is committed to achieving positive adjusted EBITDA in the “near-term,” without specifying a timeline.

This REIT ETF Just Hit a 52-Week Low. Here’s Why It’s Time to Buy.

Twenty-two ETFs hit 52-week highs, and 17 hit 52-week lows on Tuesday. One of the ETFs hitting a 52-week low was an Invesco REIT that’s worth considering for income-focused investors. Here’s why.

AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market

AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market PR Newswire BETHESDA, Md., Oct. 21, 2024 With...

Cannabis firm Canopy Growth Corporation was among the top trending stocks on Stocktwits on Friday after the company failed to meet first-quarter earnings estimates.The company reported an earnings loss of C$1.63 compared to an estimated loss of C$0.46 while revenue came in 13% lower on a year-over-year (YoY) basis at C$66.21 million versus an estimate of C$70.1 million.The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago.On the positive side, the company said it has entered into an amendment to its credit agreement with all of the lenders to its senior secured term loan. According to the new agreement, the firm will see significant deleveraging of up to US$200 million.Following the announcement, retail sentiment continued to trend in the ‘bullish territory’ (61/100) although the score inched-down a bit compared to Thursday.<figure class="image"><a href="https://stocktwits.com/symbol/CGC"><img style="aspect-ratio:1888/530;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_08_09_at_9_33_52_AM_c532f1dba8.png" alt="Canopy Growth sentiment meter as of 9:09 a.m. EST on August 09, 2024" width="1888" height="530"></a><figcaption>Canopy Growth sentiment meter as of 9:09 a.m. EST on August 09, 2024</figcaption></figure>Judy Hong, Chief Financial Officer of Canopy Growth Corporation said the firm’s strategic initiatives have led to notable improvements in gross margins and adjusted operating profit as well as reduction in selling, general and administrative (SG&amp;A) expenses. “We are pleased that all of our business units delivered positive Adjusted EBITDA during Q1 Fiscal 2025 and expect to achieve positive Adjusted EBITDA on a consolidated basis in the second half of the fiscal year,” Hong said.On a segmental basis, Canada cannabis net revenue came in at C$38MM in Q1FY2025, registering a decrease of 6% YoY. At the same time, international markets cannabis net revenue declined 1%.The firm also posted a deal update with Canopy USA closing the acquisitions of approximately 75% of the shares of Lemurian, Inc. and two of three Wana entities — Wana Wellness, LLC and The CIMA Group.Stocktwits users are expressing optimism after the earnings announcement and are bullish on the firm’s prospects following the balance sheet restructuring.<stembedurl>https://stocktwits.com/KLONDIKER/message/582426681</stembedurl>Additionally, comments from Republican presidential nominee Donald Trump on Monday suggested a looser policy stance toward Cannabis could be coming, which helped buoy sentiment toward the overall sector.

reported an earnings loss of C$1.63 compared to an estimated loss of C$0.46

Why This Cannabis Firm Is Among The Top Trending On Stocktwits Today

The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago.

The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago. On the positive side, however, the company said it has entered into an amendment to its credit agreement with all of the lenders to its senior secured term loan

Advisorshares Trust - AdvisorShares Pure Cannabis ETF

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

Current Price	$2.92
Prev Close	$2.94
Open	$2.92
Dividend Yield	N/A
50-Day Moving Average	$3.19
Beta	N/A
Avg. Volume	36,736.68
PE Ratio	N/A

52-Week High	$3.94
52-Week Low	$1.45
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

YOLO
AdvisorShares Pure Cannabis ETF

Feed

News

Sentiment

Fundamentals

Info

Latest YOLO News

YOLOAdvisorShares Pure Cannabis ETF